Eptinezumab Antibody

Eptinezumab is a humanized monoclonal antibody designed for migraine prevention by selectively targeting the calcitonin gene-related peptide (CGRP) . It functions by inhibiting CGRP from binding to its receptor, thereby blocking this pathway implicated in migraine pathophysiology. Its application extends to in vitro binding studies and in vivo models for researching CGRP-mediated mechanisms.